Latigo Biotherapeutics Inc

LTGO

Insiders bought in the last twelve months.

13.98 0.78 −5.28%
Market cap
$978.6M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '25 Dec '25 Jun '26
ROIC
— 0.00% 0.00%
Return on Tangible Assets
— 0.00% 0.00%
Free Cash Flow per Share
0.00 — 0.00
Other line items
Cash ROIC
— 0.00% 0.00%
Average Days of Payables
— 0.00 0.00
Depreciation/Fixed assets
— 0.00 0.00
Revenue per Share
0.00 — 0.00
Operating CF per Share
0.00 — 0.00
Capex per Share
0.00 — 0.00

Fold the line items

Columns are period end dates · fundamentals updated 29 Sep 2026